A supervised machine learning approach to predicting plasma biomarkers of Alzheimer's disease among diverse Hispanic/Latino adults: Findings from the SOL‐INCA study

AAIC 2025 Abstract

Abstract

Background: Plasma phosphorylated tau‐181 ( p ‐tau‐181) has emerged as a reliable blood‐based biomarker (BBM) for Alzheimer's disease (AD), reflecting tau pathology.

The paper